Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Date:

October 24, 2024

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings that showed enough cash on its balance sheet to fund key clinical trials.

Source link

Cafeteria raises $3M to connect brands with their most opinionated customers: teens

Nobel Laureate Bob Dylan accidentally visited the world’s largest publishing trade fair.

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Recent posts

‘Absurd’ to think Trump’s policies would be inflationary, says possible Treasury pick

Lemonade’s stock slides 14% after digital insurer’s soft guidance offsets narrower-than-expected loss

ECB jumps ahead of the Fed to deliver its first rate cut. Is now a good time to invest in Europe ETFs?

Harris’s $25K for home buyers would lift prices, but her housing plan has advantages, economist says

After its August selloff, the U.S. dollar may face more downside risk ahead

Biden officials tout grants to retool factories for EVs, including in swing states

Another billionaire investor positions for a Trump win. He’s placing ‘inflation trades.’

Trump’s plans for deportations, tariffs and the Fed will jack up inflation, economists say

Worries about deficit spending after election bog down U.S. government debt

NASA astronauts ‘confident’ in Boeing Starliner’s ability to get them home safely

Monster Beverages’ stock is sinking. Executives are blaming convenience stores.

Tommy Hilfiger and Calvin Klein parent PVH Corp. raises profit outlook despite ‘continued tough macroeconomic backdrop’

Silver’s scarcity factor is helping it catch up to gold’s record run

What a 10-year Treasury yield above 4% says about the economy

Two Magnificent Seven companies report this week. Only one will likely be among the biggest profit drivers.

Related articles

Polymarket says the whale betting heavily on Trump is a French individual

Harley-Davidson’s stock down 2% as lowered guidance offsets earnings beat

Harris trades: These healthcare stocks could rally if she wins — or drop if Trump triumphs

Boeing unveils $6 billion quarterly loss ahead of key vote by striking machinists

Another billionaire investor positions for a Trump win. He’s placing ‘inflation trades.’

Stocks usually see double-digit gains under U.S. presidents — with two exceptions since 1933

Oil on track for back-to-back gain on China stimulus, lingering Middle East worries

Kimberly-Clark’s stock falls after sales fall short, with declines in tissues and personal care

Company

Follow us